HCV envelop protein E2 posses glycosylation sites which interact directly with the cell surface receptors CD81, SR-BI and CLDN1 [67-69], confirming their role in HCV entry by using HCVpp or HCVcc infection in liver cell lines [70-73]. This evidence concerns the gene CLDN1 and infection.